HAB Pharma, Signature Phytochemicals merge to form Rs. 600 crore integrated pharma entity
Combined company targets Rs. 2,500–3,000 crore revenue by 2030; new sterile and OSD plants to begin operations by August 2026
Combined company targets Rs. 2,500–3,000 crore revenue by 2030; new sterile and OSD plants to begin operations by August 2026
The platform combines internally developed technologies, strategic partnerships, and external AI capabilities
Union health ministry secretary Punya Salila Srivastava lauds HLL’s six decades of contribution to public healthcare and social development
Access to genomic testing, not therapy cost, is the biggest challenge
The Ibuprofen business posted a negative EBITDA of Rs. 179 million in Q4 despite revenue rising 61% year-on-year to Rs. 849 million
The two companies will establish a joint Center of Excellence (CoE) in Bengaluru
Collaboration to deliver scalable automation solutions for electronics, semiconductor, medical manufacturing, and intralogistics sectors
Subscribe To Our Newsletter & Stay Updated